ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patients.

Clara G Chisari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.